openPR Logo
Press release

Investigation announced for Investors in shares of FOXO Technologies Inc. (NYSE American: FOXO)

11-28-2022 09:59 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in FOXO Technologies Inc. (NYSE American: FOXO) shares over potential securities laws violations.

An investigation for investors in FOXO Technologies Inc. (NYSE American: FOXO) shares over potential securities laws violations.

An investigation was announced for investors of FOXO Technologies Inc. (NYSE American: FOXO) shares over potential securities laws violations by FOXO Technologies Inc.

Investors who purchased shares of FOXO Technologies Inc. (NYSE American: FOXO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by FOXO Technologies Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Minneapolis, MN based FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry.

On February 24, 2022, FOXO Technologies Inc entered into a definitive merger agreement with special purpose acquisition company Delwinds Insurance Acquisition Corp. ("Delwinds") (NYSE: DWIN).
On September 15, 2022, FOXO Technologies Inc launched its initial public offering ("IPO") through a reverse merger with a special purpose acquisition company ("SPAC"), Delwinds. The stock opened for trading at $7.29 per share.
On November 14, 2022, FOXO Technologies Inc Technologies postponded its Third Quarter 2022 Earnings Report and Conference Call.
On November 14, 2022, FOXO Technologies Inc Technologies announced the departure of Chief Product Officer, Erin Sharoni.

Shares of FOXO Technologies Inc. (NYSE American: FOXO) declined to as low as $0.418 per share on November 17, 2022.

Those who purchased shares of FOXO Technologies Inc. (NYSE American: FOXO) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of FOXO Technologies Inc. (NYSE American: FOXO) here

News-ID: 2824968 • Views:

More Releases from Shareholders Foundation

Lawsuit filed for certain Investors who lost money with shares of Global Cord Blood Corporation (OTC: CORBF)
Lawsuit filed for certain Investors who lost money with shares of Global Cord Bl …
An investor, who purchased shares of Global Cord Blood Corporation (OTC: CORBF), filed a lawsuit over alleged violations of Federal Securities Laws by Global Cord Blood Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Global Cord Blood Corporation (OTC: CORBF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 24, 2024. OTC: CORBF investors should contact the Shareholders
Lawsuit filed for Investors who lost money with shares of Autodesk, Inc. (NASDAQ: ADSK)
Lawsuit filed for Investors who lost money with shares of Autodesk, Inc. (NASDAQ …
An investor, who purchased shares of Autodesk, Inc. (NASDAQ: ADSK), filed a lawsuit over alleged violations of Federal Securities Laws by Autodesk, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Autodesk, Inc. (NASDAQ: ADSK) have certain options and for certain investors are short and strict deadlines running. Deadline: June 24, 2024. NASDAQ: ADSK investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Investors who lost money with shares of AST SpaceMobile, Inc. (NASDAQ: ASTS) should contact the Shareholders Foundation in connection with pending lawsuit
Investors who lost money with shares of AST SpaceMobile, Inc. (NASDAQ: ASTS) sho …
An investor, who purchased shares of AST SpaceMobile, Inc. (NASDAQ: ASTS), filed a lawsuit over alleged violations of Federal Securities Laws by AST SpaceMobile, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of AST SpaceMobile, Inc. (NASDAQ: ASTS) have certain options and for certain investors are short and strict deadlines running. Deadline: June 17, 2024. NASDAQ: ASTS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors who lost money with shares of Sharecare, Inc. (NASDAQ: SHCR)
Lawsuit filed for Investors who lost money with shares of Sharecare, Inc. (NASDA …
An investor, who purchased shares of Sharecare, Inc. (NASDAQ: SHCR), filed a lawsuit over alleged violations of Federal Securities Laws by Sharecare, Inc. Investors who purchased shares of Sharecare, Inc. (NASDAQ: SHCR) have certain options and for certain investors are short and strict deadlines running. Deadline: June 18, 2024. NASDAQ: SHCR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Atlanta, GA based Sharecare, Inc. operates as

All 5 Releases